Cytomegalovirus-induced haemophagocytic lymphohistiocytosis syndrome.
Haematology-Oncology Department, Henry Ford Hospital, Detroit, Michigan, USA. javier.munoz@me.com
Javier
J
Munoz
Naushin
N
Shareef
Vijayalakshmi
V
Donthireddy
D016572:Cyclosporine / Q000627:therapeutic use; D003586:Cytomegalovirus Infections / Q000150:complications*; D003907:Dexamethasone / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D005047:Etoposide / Q000627:therapeutic use; D005260:Female; D015774:Ganciclovir / Q000627:therapeutic use; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D051359:Lymphohistiocytosis, Hemophagocytic / Q000175:diagnosis / Q000628:therapy / Q000821:virology*; D012121:Respiration, Artificial; D013577:Syndrome; D055815:Young Adult
D016756:Immunoglobulins, Intravenous; D005047:Etoposide; D003907:Dexamethasone; D016572:Cyclosporine; D015774:Ganciclovir